Search

everythinglearnresearchcommunity

for

Search:↓

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Lichen planopilaris can be triggered by prolonged scalp traction and can be treated with corticosteroids.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Treat active lichen planopilaris early to prevent permanent hair loss.

Combining low-level laser therapy with topical corticosteroids effectively improved Lichen Planopilaris symptoms.

The patient responded well to treatment with no disease progression.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

GLPLS and LPP are variants of lichen planus.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Tripeptides help heal wounds and regenerate skin by speeding up tissue repair and reducing inflammation.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Targeting LPA could help treat skin disorders.

Lipid-polymer hybrid nanoparticles show promise for skin treatments but need better formulation strategies.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Linear lichen planopilaris can affect the trunk, not just the face.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.